Anti-Human κ Opioid Receptor Antibodies: Characterization of Site-Directed Neutralizing Antibodies Specific for a Peptide κR(33-52) Derived from the Predicted Amino Terminal Region of the Human κ Receptor

Journal of Immunology

Volumn 158, Issue 4, 1997, Pages 1670-1680

  Buchner, Robert R ^a   Vogen, Shawn M ^b   Fischer, Wolfgang ^a   Thoman, Marilyn L ^a   Sanderson, Sam D ^b   Morgan, Edward L ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISERUM; BLOCKING ANTIBODY; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENT; KAPPA OPIATE RECEPTOR; MESSENGER RNA; PEPTIDE FRAGMENT;

ADULT; AMINO ACID SEQUENCE; ANTIBODY COMBINING SITE; ANTIBODY SPECIFICITY; ARTICLE; BIOSYNTHESIS; CELL LINE; CHEMISTRY; DRUG ANTAGONISM; FEMALE; GENETICS; HISTIOCYTIC LYMPHOMA; HUMAN; IMMUNOLOGY; LEUKEMIA CELL LINE; LYMPHOCYTE ACTIVATION; MALE; MOLECULAR GENETICS; MONOCYTE; NEUROBLASTOMA; NUCLEOTIDE SEQUENCE;

ADULT; AMINO ACID SEQUENCE; ANTIBODIES, BLOCKING; ANTIBODY SPECIFICITY; BASE SEQUENCE; BINDING SITES, ANTIBODY; CELL LINE; FEMALE; HUMANS; IMMUNE SERA; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; JURKAT CELLS; LYMPHOCYTE ACTIVATION; LYMPHOMA, LARGE-CELL; MALE; MOLECULAR SEQUENCE DATA; MONOCYTES; NEUROBLASTOMA; PEPTIDE FRAGMENTS; RECEPTORS, OPIOID, KAPPA; RNA, MESSENGER;

EID: 0031568393     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Weigent, D. A., and J. E. Blalock. 1987. Interactions between the neuroendocrine and immune systems: common hormones and receptors. Immunol. Rev. 100:79.
2. Rouveix, B. 1988. Opiates and immune function: consequences on infectious diseases with special references to AIDS. Therapie 47:503.
3. Sibinga, N. E. S., and A. Goldstein. 1989. Opioid peptides and opioid receptors in cells of the immune system. Annu. Rev. Immunol. 6:219.
4. Brown, S. L., L. R. Smith, and J. E. Blalock. 1987. Interleukin 1 and interleukin 2 enhance proopiomelanocortin gene expression in pituitary cells. J. Immunol. 139:3181.
5. Fagarasan, M. O., R. Eskay, and J. Axelrod. 1989. Interleukin 1 potentiates the secretion of β-endorphin induced secretagogues in the primary pituitary cell line (AtT-20). Proc. Natl. Acad. Sci. USA 86:2070.
6. Carr, D. J. 1991. The role of endogenous opioids and their receptors in the immune system. Proc. Soc. Exp. Biol. Med. 198:710.
7. Farrar, W. L., J. M. Hill, A. Harel-Bellan, and M. Vincou. 1987. The immune logical brain. Immunol. Rev. 100:361.
8. Johnson, H. M., E. M. Smith, B. A. Torres, and J. E. Blalock. 1982. Regulation of the in vitro antibody response by neuroendocrine hormones. Proc. Natl. Acad. Sci. USA 79:4171.
9. Heijnen, C. J., C. Bevers, A. Kavelaars, and R. E. Ballieux. 1986. Effects of alpha-endorphin on the antigen-induced primary response of human blood B cells in vitro. J. Immunol. 136:213.
10. Morgan, E. L., M. R. McClurg, and J. A. Janda. 1990. Suppression of B lymphocyte activation by β-endorphin. J. Neuroimmunol. 28:209.
11. Morgan, E. L. 1996. Regulation of human B lymphocyte activation by opioid peptide hormones: inhibition of IgG production by opioid receptor class (μ-, κ-, and, δ-) selective agonists. J. Neuroimmunol. 65:21.
12. Hucklebridge, F. H., B. N. Hudspith, J. Muhamed, P. M. Lydyard, and J. Brostoff. 1989. Methionine-enkephalin stimulates in vitro proliferation of human peripheral lymphocytes via delta-opioid receptors. Brain Behav. Immun. 3:183.
13. Arakawa, K., T. Akami, M. Okamoto, K. Akioka, I. Nakai, T. Oka, and H. Nagase. 1993. Immunosuppression by delta opioid receptor agonists. Transplant. Proc. 25:738.
14. Carr, D. J., B. M. Gebhardt, and D. Paul. 1993. Alpha adrenergic and mu-2 opioid receptors are involved in morphine-induced suppression of splenocyte natural killer activity. J. Pharmacol. Exp. Ther. 264:1179.
15. Chiappelli, F., N. Yamashita, M. Faisal, M. Kemeny, R. Bullington, L. Nguyen, L. T. Clement, and J. L. Fahey. 1991. Differential effect of beta-endorphin on three human cytotoxic cell populations. Int. J. Immunopharmacol. 13:291.
16. Makman, M. H., T. V. Bilfinger, and G. B. Stefano. 1995. Human granulocytes contain an opiate alkaloid-selective receptor mediating inhibition of cytokine-induced activation and chemotaxis. J. Immunol. 154:1323.
17. De Carolis, C., G. De Sanctis, R. Perricone, C. Moretti, A. Fabbrl, L. Gnessi, F. Fraioli, and L. Fontana. 1984. Evidence for an inhibitory role of beta-endorphin and other opioids on human total T rosette formation. Experimentia 40:738.
18. Peterson, P. K., B. Sharp, G. Gekker, C. Brummitt, and W. F. Keane. 1987. Opioid mediated suppression of cultured peripheral blood mononuclear cell respiratory burst activity. J. Immunol. 138:3907.
19. James, I. F., and A. Goldstein. 1984. Site-directed alkylation of multiple opioid receptors. I. Binding selectivity. Mol. Pharmacol. 25:337.
20. Dixon, W. R., O. H. Viveros, C. D. Unsworth, E. J. Diliberto, E. L. Way, A. Lewis, J. W. Chandra, J. B. Holaday, J. B. Long, and F. C. Tortella. 1985. Multiple opiate receptors: functional implications. Fed. Proc. 44:2856.
21. Zhu, J., C. Chen, J. C. Xhe, S. Kunapuli, J. K. DeRiel, and L. Y. Liu-Chen. 1995. Cloning of a human kappa opioid receptor from the brain. Life Sci. 56:201.
22. Simonin, F., C. Gaveriaux-Ruff, K. Befort, H. Matthes, B. Lannes, G. Micheletti, M. G. Mattei, G. Charron, B. Bloch, and B. Kiefer. 1995. Kappa opioid receptor in humans: cDNA and genomic cloning, chromosomal assignment, functional expression, pharmacology, and expression pattern in the central nervous system. Proc. Natl. Acad. Sci. USA 92:7006.
23. Simonin, F., K. Befort, C. Gaveriaux-Ruff, H. Matthes, V. Nappey, B. Lannes, M. Micheletti, and B. Kieffer. 1994. The human delta opioid receptor: genomic organization, cDNA cloning, functional expression, and distribution in the human brain. Mol. Pharmacol. 26:1015.
24. Handa, B. K., A. C. Lane, J. A. H. Lord, B. A. Morgan, M. J. Rance, and C. F. C. Smith. 1981. Analogues of beta-LPH61-64 possessing selective agonists activity at mu-opiate receptors. Eur. J. Pharmacol. 70:531.
25. Mosberg, H. I., R. Hurst, V. J. Hruby, K. Gee, H. I. Yamamura, J. J. Galligan, and T. F. Burks. 1982. Bis-penicillamine enkephalins possess highly improved specificity towards delta-opioid receptors. Proc. Natl. Acad. Sci. USA 80:5871.
26. Von Voitlander, P. F., R. A. Lahti, and J. H. Lunden. 1983. U50,488H: a stereoactive and structurally novel non-mu (kappa) opioid agonist. J. Pharmacol. Exp. Ther. 224:7.
27. Shook, J. E., W. Kazmierski, W. S. Wire, P. K. Lemcke, V. J. Hruby, and T. F. Burks. 1988. Opioid receptor selectivity of β-endorphin in vitro and in vivo: mu, delta, and epsilon receptors. J. Pharmacol. Exp. Ther. 246:1018.
28. Chuang, L. F., T. K. Chuang, K. F. Killam, A. J. Chuang, H. F. Kung, L. Lu, and R. Y. Chuang. 1994. Delta opioid receptor gene expression in lymphocytes. Biochem. Biophys. Res. Commun. 202:1291.
29. Gaveriaux, P. J., F. Simonin, L. Laforet, and B. Kiefffer. 1995. Identication of kappa-and delta-opioid receptor transcripts in immune cells. FEBS Lett. 369:272.
30. Carr, D. J., R. T. Radulescu, B. R. deCosta, K. C. Rice, and J. E. Blalock. 1990. Differential effect of opioids on immunoglobulin production by lymphocytes isolated from Peyer's patches and spleen. Life Sci. 47:1059.
31. Oleson, D. R., and D. R. Johnson. 1988. Regulation of human natural cytotoxicity by enkephalins and selective opiate antagonists. Brain Behav. Immun. 2:171.
32. Morgan, E. L., and W. O. Weigle. 1981. Polyclonal activation of human B lymphocytes by Fc fragments. I. Characterization of the cellular requirements for Fc fragment-mediated polyclonal antibody secretion by human peripheral blood B lymphocytes. J. Exp. Med. 154:778.
33. Sanderson, S. D., L. Kirnarsky, S. A. Sherman, J. A. Ember, A. M. Finch, and S. M. Taylor. 1994. Decapeptide agonists of human C5a: the relationship between conformation and spasmogenic and platelet aggregatory responses. J. Med. Chem. 38:3171.
34. 33a. Tempero, R. M., M. A. Hollingsworth, M. D. Burdick, A. M. Finch, S. M. Taylor, S. M. Vogen, E. L. Morgan, and S. D. Sanderson. 1997. Molecular adjuvant effects of a conformationally biased agonist of human C5a anaphylatoxin. J. Immunol. In press.
35. Morgan, E. L., J. A. Ember, S. D. Sanderson, W. Scholz, R. Buchner, R. D. Ye, and T. E. Hugli. 1993. Anti-C5a receptor antibodies. I. Characterization of neutralizing antibodies specific for the human C5a receptor. J. Immunol. 151:377.
36. Hobbs, M. V., R. A. Houghten, J. A. Janda, W. O. Weigle, and E. L. Morgan. 1989. Induction of human B cell differentiation by Fc region activators. I. Identification of an active tetrapeptide. Clin. Immunol. Immunopathol. 50:251.
37. Belkowski, S. M., J. Zhu, L. Chen, T. K. Eisenstein, M. W. Adler, and T. J. Rogers. 1995. Sequence of kappa-opioid receptor cDNA in the R1.1 thymoma cell line. J. Neuroimmunol. 62:113.
38. Carr, D. J., B. R. DeCosta, C. H. Kim, A. E. Jacobson, V. Guarcello, K. C. Rice, and J. E. Blalock, J. E. 1989. Opioid receptors on cells of the immune system: evidence for delta-and kappa-classes. J. Neuroendocrinol. 122:161.
39. Carr, D. J., B. R. DeCosta, C. H. Kim, A. E. Jacobson, K. L. Bost, K. C. Rice, and J. E. Blalock. 1990. Anti-opioid receptor antibody recognition of a binding site on brain and leukocyte opioid receptors. Neuroendocrinology 51:552.
40. Garzon, J., and P. Sanchez-Blazquez. 1996. The in vivo injection of antibodies direct against cloned mu opioid receptor blocked supraspinal analgesia induced by mu-agonists in mice. Life Sci. 56:237.
41. Metzger, T. M., and D. M. Ferguson. 1996. On the role of extracellular loops of opioid receptors in conferring ligand selectivity. FEBS Lett. 375:1.
42. Xue, J. C., C. Chen, J. Zhu, S. Kunapuli, J. K. DeRiel, L. Yu, and L. Y. Liu-Chen. 1994. Differential binding domains of peptide and non-peptide ligands in cloned rat kappa opioid receptor. J. Biol. Chem. 269:30195.
43. Galin, F. S., R. D. LeBoeuf, and J. E. Blalock. 1990. A lymphocyte mRNA encodes the adrenocorticotropin/beta-lipotropin region of the proopiomelanocortin gene. Prog. Neuroendocrinol. 3:205.
44. Westly, H. J., A. J. Kleiss, K. W. Kelley, P. K. Y. Wong, and P. K. Yuen. 1986. Newcastle disease virus-infected splenocytes express the proopiomelanocortin gene. J. Exp. Med. 163:1589.
45. Zurawski, G., M. Bebedik, B. J. Kamb, J. S. Abrams, S. M. Zurawski, and F. D. Lee. 1986. Activation of mouse T-helper cells induce abundant preproenkephalin mRNA synthesis. Science 232:772.
46. Monstein, H. J., J. R. Folksson, and L. Terenius. 1986. Proenkephalin A-like mRNA in human leukemia lymphocytes and CNS-tissues. Life Sci. 39.2237.
47. Walker, J. S., C. R. Howlett, and V. Nayanar. 1995. Anti-inflammatory effects of kappa-opioids in adjuvant arthritis. Life Sci. 57:371.
48. Radulovic, J., D. Djergovic, C. Miljevic, and B. D. Jankovic. 1994. Kappa-opioid receptor functions: possible relevance to experimental allergic encephalomyelitis. Neuroimmunomodulation 4:236.